Prospects for Tuberculosis Elimination

被引:294
作者
Dye, Christopher [1 ]
Glaziou, Philippe [2 ]
Floyd, Katherine [2 ]
Raviglione, Mario [2 ]
机构
[1] WHO, Off Hlth Informat, CH-1211 Geneva 27, Switzerland
[2] WHO, Stop TB Dept, CH-1211 Geneva 27, Switzerland
来源
ANNUAL REVIEW OF PUBLIC HEALTH, VOL 34 | 2013年 / 34卷
关键词
diagnosis; drugs; vaccines; transmission; latent infection; human immunodeficiency virus; HIV; LATENT TUBERCULOSIS; DIAGNOSTICS; INFECTION; PREVALENCE; CHALLENGES; EPIDEMIC; THERAPY; VACCINE; BURDEN; RISKS;
D O I
10.1146/annurev-publhealth-031912-114431
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The target for TB elimination is to reduce annual incidence to less than one case per million population by 2050. Meeting that target requires a 1,000-fold reduction in incidence in little more than 35 years. This can be achieved only by combining the effective treatment of active TB-early case detection and high cure rates to interrupt transmission-with methods to prevent new infections and to neutralize existing latent infections. Vigorous implementation of the WHO Stop TB Strategy is needed to achieve the former, facilitated by the effective supply of, and demand for, health services. The latter calls for new technology, including biomarkers of TB risk, diagnostics, drugs, and vaccines. An important milestone en route to elimination will be reached when there is less than 1 TB death per 100,000 population, marking entry into the elimination phase. This landmark can be reached by many countries within 1-2 decades.
引用
收藏
页码:271 / +
页数:37
相关论文
共 66 条
[1]   A multistage tuberculosis vaccine that confers efficient protection before and after exposure [J].
Aagaard, Claus ;
Hoang, Truc ;
Dietrich, Jes ;
Cardona, Pere-Joan ;
Izzo, Angelo ;
Dolganov, Gregory ;
Schoolnik, Gary K. ;
Cassidy, Joseph P. ;
Billeskov, Rolf ;
Andersen, Peter .
NATURE MEDICINE, 2011, 17 (02) :189-U224
[2]  
[Anonymous], 2011, Global Tuberculosis Control 2011
[3]  
[Anonymous], 2012, WHO policy on collaborative TB/HIV activities: guidelines for national programmes and other stakeholders
[4]  
[Anonymous], 2011, Global Health and Aging
[5]   The spectrum of latent tuberculosis: rethinking the biology and intervention strategies [J].
Barry, Clifton E., III ;
Boshoff, Helena I. ;
Dartois, Veronique ;
Dick, Thomas ;
Ehrt, Sabine ;
Flynn, JoAnne ;
Schnappinger, Dirk ;
Wilkinson, Robert J. ;
Young, Douglas .
NATURE REVIEWS MICROBIOLOGY, 2009, 7 (12) :845-855
[6]  
Berkeley Madonna, 2007, BERK MAD MOD AN DYN
[7]   A Dynamic Reinfection Hypothesis of Latent Tuberculosis Infection [J].
Cardona, P. -J. .
INFECTION, 2009, 37 (02) :80-86
[8]  
Cent. Dis. Control Prev. (CDC), 2012, TUB TB
[9]  
Chen XY, 2004, LANCET, V364, P417
[10]   Which New Diagnostics for Tuberculosis, and When? [J].
Cobelens, Frank ;
van den Hof, Susan ;
Pai, Madhukar ;
Squire, S. Bertel ;
Ramsay, Andrew ;
Kimerling, Michael E. .
JOURNAL OF INFECTIOUS DISEASES, 2012, 205 :S191-S198